Figure 1:

ERA countries with the lowest adjusted KRT incidence (<100 pmp) in 2018. (A) Geographical localization. Colour-coding is for adjusted KRT prevalence. KRT prevalence was chosen as it is more stable than incidence for countries with a small number of inhabitants and KRT patients. Source: Kramer et al. [12]. (B) Relationship between adjusted CKD prevalence in 2017 and adjusted KRT prevalence in 2018 among ERA countries with the lowest KRT incidence in 2018. Note that higher CKD prevalence is not associated with higher KRT prevalence. In this regard, Iceland and Finland both had a low prevalence of CKD and a low incidence and prevalence of KRT and may be considered benchmark countries for achieving low CKD prevalence and low need of KRT. Data from Jonsson et al. [11] and GBD Chronic Kidney Disease Collaboration [13]. Vertical discontinuous line represents the KRT prevalence in all ERA countries combined.